The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder

References

• Anglin, D. M., Corcoran, C. M., Brown, A. S., Chen, H., Lighty, Q., Brook, J. S., & Cohen, P. R. (2012). Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophrenia Research, 137(1–3), 45–49. doi:10.1016/j.schres.2012.01.019
   PubMed Web of Science ®Google Scholar
• Barrowclough, C., Emsley, R., Eisner, E., Beardmore, R., & Wykes, T. (2013). Does change in cannabis use in established psychosis affect clinical outcome? Schizophrenia Bulletin, 39(2), 339–348. doi:10.1093/schbul/sbr152
   PubMed Web of Science ®Google Scholar
• Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., … Craig, I. W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57(10), 1117–1127. doi:10.1016/j.biopsych.2005.01.026
   PubMed Web of Science ®Google Scholar
• D'Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., … Krystal, J. H. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry, 57(6), 594–608. doi:10.1016/j.biopsych.2004.12.006
   PubMed Web of Science ®Google Scholar
• D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., … Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 29(8), 1558–1572. doi:10.1038/sj.npp.1300496
   PubMed Web of Science ®Google Scholar
• Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., … Murray, R. M. (2009). High-potency cannabis and the risk of psychosis. British Journal of Psychiatry, 195(6), 488–491. doi:10.1192/bjp.bp.109.064220
   PubMed Web of Science ®Google Scholar
• Dillon, F. R., Turner, C. W., Robbins, M. S., & Szapocznik, J. (2005). Concordance among biological, interview, and self-report measures of drug use among African American and Hispanic adolescents referred for drug abuse treatment. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 19(4), 404–413. doi:10.1037/0893-164X.19.4.404
   PubMed Web of Science ®Google Scholar
• Dragt, S., Nieman, D. H., Schultze-Lutter, F., van der Meer, F., Becker, H., de Haan, L., … Linszen, D. H. (2012). Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatrica Scandinavica, 125(1), 45–53. doi:10.1111/j.1600-0447.2011.01763.x
   PubMed Web of Science ®Google Scholar
• Faridi, K., Joober, R., & Malla, A. (2012). Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis. Schizophrenia Research, 141(1), 78–82. doi:10.1016/j.schres.2012.07.023
   PubMed Web of Science ®Google Scholar
• Green, B., Young, R., & Kavanagh, D. (2012). Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry, 187(4), 306–313. doi:10.1192/bjp.187.4.306
   Web of Science ®Google Scholar
• Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., & Murray, R. M. (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin, 34(6), 1111–1121. doi:10.1093/schbul/sbn108
   PubMed Web of Science ®Google Scholar
• Henquet, C., Rosa, A., Krabbendam, L., Papiol, S., Fananás, L., Drukker, M., … van Os, J. (2006). An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 31(12), 2748–2757. doi:10.1038/sj.npp.1301197
   PubMed Web of Science ®Google Scholar
• Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006). Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study. British Journal of Psychiatry, 189(Aug.), 137–143. doi:10.1192/bjp.bp.105.014308
   PubMed Web of Science ®Google Scholar
• Hides, L., Lubman, D. I., Buckby, J., Yuen, H. P., Cosgrave, E., Baker, K., & Yung, A. R. (2009). The association between early cannabis use and psychotic-like experiences in a community adolescent sample. Schizophrenia Research, 112(1–3), 130–135. doi:10.1016/j.schres.2009.04.001
   PubMed Web of Science ®Google Scholar
• Hjorthøj, C., Fohlmann, A., Larsen, A. M., Arendt, M., & Nordentoft, M. (2012). Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction, 107(6), 1123–1131. doi:10.1111/j.1360-0443.2011.03757.x
   PubMed Web of Science ®Google Scholar
• Hjorthøj, C., Fohlmann, A., Larsen, A.-M., Gluud, C., Arendt, M., & Nordentoft, M. (2012). Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: The CapOpus randomized trial. Psychological Medicine, 43(7), 1–12. doi:10.1017/S0033291712002255
   PubMed Web of Science ®Google Scholar
• Hjorthøj, C., Fohlmann, A., Larsen, A.-M., Madsen, M. T. R., Vesterager, L., Gluud, C., … Nordentoft, M. (2008). Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials, 9, 42. doi:10.1186/1745-6215-9-42
   PubMed Web of Science ®Google Scholar
• Hjorthøj, C., Hjorthøj, A. R., & Nordentoft, M. (2012, December 12). Validity of timeline follow-back for self-reported use of cannabis and other illicit substances—systematic review and meta-analysis. Addictive Behaviors, 37, 225–233. doi:10.1016/j.addbeh.2011.11.025
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Opler, L. A., & Lindenmayer, J. P. (1989). The Positive and Negative Syndrome Scale (PANSS): Rationale and standardisation. British Journal of Psychiatry, 155(Nov. Suppl. 7), 59–65. doi:10.1093/schbul/13.2.261
   Google Scholar
• Large, M., Mullin, K., Gupta, P., Harris, A., & Nielssen, O. (2014). Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use. The Australian and New Zealand Journal of Psychiatry, 48(5), 418–432. doi:10.1177/0004867414525838
   PubMed Web of Science ®Google Scholar
• McGrath, J., Welham, J., Scott, J., Varghese, D., Degenhardt, L., Hayatbakhsh, M. R., … Najman, J. M. (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry, 67(5), 440–447. doi:10.1001/archgenpsychiatry.2010.6
   PubMed Web of Science ®Google Scholar
• McLaren, J. A., Silins, E., Hutchinson, D., Mattick, R. P., & Hall, W. (2010). Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies. International Journal of Drug Policy, 21(1), 10–19. doi:10.1016/j.drugpo.2009.09.001
   PubMed Web of Science ®Google Scholar
• Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (vol. 2nd). New York, NY: Guilford.
   Google Scholar
• Morgan, C. J. A, & Curran, H. V. (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. British Journal of Psychiatry, 192(4), 306–307. doi:10.1192/bjp.bp.107.046649
   PubMed Web of Science ®Google Scholar
• Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717–734.
   PubMed Web of Science ®Google Scholar
• Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services (Washington, DC), 51(2), 216–222. doi:10.1176/appi.ps.51.2.216
   PubMed Web of Science ®Google Scholar
• Schimmelmann, B. G., Conus, P., Cotton, S., Kupferschmid, S., McGorry, P. D., & Lambert, M. (2012). Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. European Psychiatry, 27(6), 463–469. doi:10.1016/j.eurpsy.2011.03.001
   PubMed Web of Science ®Google Scholar
• Schimmelmann, B. G., Conus, P., Cotton, S. M., Kupferschmid, S., Karow, A., Schultze-Lutter, F., … Lambert, M. (2011). Cannabis use disorder and age at onset of psychosis–A study in first-episode patients. Schizophrenia Research, 129(1), 52–56. doi:10.1016/j.schres.2011.03.023
   PubMed Web of Science ®Google Scholar
• Sobell, L., & Sobell, M. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. In R. Z. Litten & J. Allen (Eds.), Measuring alcohol consumption (pp. 41–72). Totowa, NJ: Humana Press. doi:10.1007/978-1-4612-0357-5_3
   Google Scholar
• van Gastel, W. A., Vreeker, A., Schubart, C. D., MacCabe, J. H., Kahn, R. S., & Boks, M. P. M. (2014). Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences. Schizophrenia Research, 157(1–3), 266–270. doi:10.1016/j.schres.2014.04.023
   PubMed Web of Science ®Google Scholar
• Waldron, H. B., Slesnick, N., Brody, J. L., Turner, C. W., & Peterson, T. R. (2001). Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology, 69(5), 802–813. doi:10.1037/0022-006X.69.5.802
   PubMed Web of Science ®Google Scholar
• Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., … Pantelis, C. (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin, 38(2), 316–330. doi:10.1093/schbul/sbq079
   PubMed Web of Science ®Google Scholar
• Zammit, S., Owen, M. J., Evans, J., Heron, J., & Lewis, G. (2011). Cannabis, COMT and psychotic experiences. British Journal of Psychiatry, 199(5), 380–385. doi:10.1192/bjp.bp.111.091421
   PubMed Web of Science ®Google Scholar